What is the additional mean IOP reduction of alpha-agonists?

Unlock all questions

This demo includes only 20 questions. Upgrade to access hundreds of questions, flashcards, exam simulations, and disable ads.

Full question bankExam simulationsFlashcards
From $25.99Unlock all

Boost your readiness for the Primary Open-Angle Glaucoma Test. Utilize flashcards and multiple-choice questions complete with hints and detailed explanations to enhance your understanding.

Multiple Choice

What is the additional mean IOP reduction of alpha-agonists?

Explanation:
Alpha-adrenergic agonists lower IOP mainly by reducing aqueous humor production, and they’re often used as add-on therapy to achieve further reduction. When an alpha-agonist is added to an existing glaucoma regimen, the typical additional mean IOP drop is about 3 mmHg. This figure comes from averaging results across multiple studies, reflecting the common incremental benefit rather than the maximum possible response. Individual patients can experience a bit more or less, but 3 mmHg is the standard mean addition. Larger average reductions like 5 or 7 mmHg are less typical for the added effect, though they can occur in some cases.

Alpha-adrenergic agonists lower IOP mainly by reducing aqueous humor production, and they’re often used as add-on therapy to achieve further reduction. When an alpha-agonist is added to an existing glaucoma regimen, the typical additional mean IOP drop is about 3 mmHg. This figure comes from averaging results across multiple studies, reflecting the common incremental benefit rather than the maximum possible response. Individual patients can experience a bit more or less, but 3 mmHg is the standard mean addition. Larger average reductions like 5 or 7 mmHg are less typical for the added effect, though they can occur in some cases.

More Multiple Choice Questions
Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy